June 30 (Reuters) - A bipartisan group of U. lawmakers has opened national security investigations into whether drugmakers Merck and AbbVie have been involved in clinical trials conducted in China that helped fuel the communist country's military capability, according to letters seen by Reuters.
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
146last 24h
874last 7d
145● bullish (7d)
96● bearish (7d)
214publishers
Reuters86d agobearish
Exclusive-US House committee opens investigation into Merck, AbbVie China drug trialsStocktwits120d agoneutral
ABBV Stock Gains On Winning FDA Approval For Rare Blood Cancer DrugThe U.S. Food and Drug Administration (FDA) has approved pivekimab sunirine-pvzy (sold under the brand name Decnupaz), a highly targeted therapy for adults dealing with an ultra-rare and aggressive form of blood cancer.